WESTON, Fla., Sept. 5, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company developing first-in-class drugs for inflammatory and renal diseases, is pleased to announce significant advancements in development of our lead inflammasome inhibitor candidate, IC 100.  IC 100 is a novel monoclonal antibody that inhibits the

AUSTIN, Texas, Sept. 5, 2019 /PRNewswire/ -- Superior HealthPlan has made telehealth services available to nearly 1.3 million members who are covered through the health plan statewide. The service will expand access to healthcare for Superior members while removing transportation and geographic barriers to care. "While Superior offers an expansive provider ne

BLOOMFIELD, Conn., Sept. 5, 2019 /PRNewswire/ -- Breakthrough, potentially life-changing medicines offer great promise for patients and their families. However, the high prices of the medicines – millions of dollars in some cases – threaten coverage and access by patients who may benefit. Experience the interactive Multichannel News Release here:

COLUMBIA, M.D., Sept. 5, 2019 /PRNewswire/ -- ACell, Inc. today announced the launch of their new product, Gentrix® Hiatal at the 2019 Society of Laparoendoscopic Surgeons (SLS) Minimally Invasive Surgery Week 2019 (MISWeek 2019) in New Orleans, Louisiana. Gentrix Hiatal provides physicians a new solution for hiatal

FOUNTAIN VALLEY, Calif., Sept. 5, 2019 /PRNewswire/ -- Nobles Medical Technologies II has received approval from the U.S. Food and Drug Administration (USFDA) to conduct a prospective pivotal clinical trial called "STITCH" for the expanded indication of PFO Closure for Reduction of Recurrent Ischemic Stroke.

WATERTOWN, Mass., Sept. 5, 2019 /PRNewswire/ -- Liaison International, the leader in admissions management and enrollment marketing solutions for higher education, today provided details about the robust third-cycle growth of BioMedCAS™, the Centralized Application Service (CAS™) for biomedical science programs.

SEATTLE, Sept. 5, 2019 /PRNewswire/ -- More than 90% of people who died by suicide showed symptoms of mental health conditions, yet 59% of US adults with a mental health condition received no mental health services in the past year, according to a new

CMAB Biopharma today reports a positive opinion from a recent QP audit conducted by Parexel International Co. CMAB's fully integrated CDMO facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 Good Manufacturing Practice (GMP) guidelines This achievement signals CMAB Biopharma's continuing evolution into an international CDMO capable

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- The nation's top business leaders recently endorsed a more modern view of

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- Childhood cancer is more prevalent than previously believed, with global estimates of more than 400,000 new cases diagnosed every year, according to new research from St. Jude Children's Hospital and the University of Washington. In an effort to illustrate and explore the scope of the crisis, U.S.